# A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.

> **NCT06095258** · PHASE2 · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 162 (estimated)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** Traditional Chinese medicine treatment
- **DRUG:** Western medicine treatment

## Key facts

- **NCT ID:** NCT06095258
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-02-28
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095258, "A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06095258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*